These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 3547944)

  • 21. Vascularized bone marrow transplantation and graft versus host disease: morphometric analysis of muscle.
    Woolley DS; Hou A; Strande L; Tatem L; Mathews M; Hewitt CW
    Transplant Proc; 1994 Dec; 26(6):3321-2. PubMed ID: 7998154
    [No Abstract]   [Full Text] [Related]  

  • 22. [Thalidomide 1989].
    Codina C
    Med Clin (Barc); 1989 Apr; 92(15):571-2. PubMed ID: 2666770
    [No Abstract]   [Full Text] [Related]  

  • 23. Cellular basis of acquired immunologic tolerance following total bowel transplantation in rats. I. Relation between donor lymphocyte chimerism and host-cell-mediated immunity.
    Masaki Y; Kimura H; Oohara T
    Transplant Proc; 1995 Apr; 27(2):1585-8. PubMed ID: 7536971
    [No Abstract]   [Full Text] [Related]  

  • 24. Graft versus host disease in rats made tolerant for organ allografts.
    Morrissey NJ; Blom D; Ryan C; Fisher T; Bronsther O; Orloff M
    J Surg Res; 1997 May; 69(2):307-15. PubMed ID: 9224398
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effectiveness of intrathymic inoculation of soluble antigens in the induction of specific unresponsiveness to rat islet allografts without transient recipient immunosuppression.
    Oluwole SF; Jin MX; Chowdhury NC; Ohajekwe OA
    Transplantation; 1994 Nov; 58(10):1077-81. PubMed ID: 7974714
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regulation of donor T cells in the tolerant rats to graft-versus-host disease by FTY720 following small bowel transplantation.
    Song J; Ito T; Matsuda C; Tanemura M; Nishida T; Nozawa M; Sawa Y
    Transplant Proc; 2006 Dec; 38(10):3181-3. PubMed ID: 17175216
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The influence of graft-versus-host reactivity, lymphocyte depletion, and cell dose on allogeneic bone marrow engraftment.
    Glass B; Uharek L; Gaska T; Gassmann W; Löffler H; Müller-Ruchholtz W
    Bone Marrow Transplant; 1993; 12 Suppl 3():S41-7. PubMed ID: 8124257
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Skin allograft survival following intrathymic injection of donor bone marrow.
    Cober SR; Randolph MA; Lee WP
    J Surg Res; 1999 Aug; 85(2):204-8. PubMed ID: 10423320
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tolerance induced by direct inoculation of donor antigen into the thymus in low and high responder rodents.
    Alfrey EJ; Wang X; Lee L; Holm B; Kim J; Adams G; Dafoe DC
    Transplantation; 1995 Apr; 59(8):1171-6. PubMed ID: 7732564
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The mechanism of UVB prevention of graft versus host disease.
    Greenfeld JI; Chabot JA; Oluwole SF; Hardy MA
    J Surg Res; 1996 Jan; 60(1):137-41. PubMed ID: 8592404
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Induction of tolerance by intrathymic injection of donor bone marrow cells in the rat: simultaneous heart and skin allograft model.
    Imanishi M; Matsuura T; Hara Y; Tahara H; Kurita T
    Transplant Proc; 1994 Aug; 26(4):1958-9. PubMed ID: 7520615
    [No Abstract]   [Full Text] [Related]  

  • 32. Multilineage amplification of graft-vs-host disease-resistant chimerism following rat vascularized bone marrow allotransplantation.
    Llull R; Murase N; Demetris AJ; Ye Q; Manez R; Starzl TE
    Transplant Proc; 1995 Aug; 27(4):2363-4. PubMed ID: 7544504
    [No Abstract]   [Full Text] [Related]  

  • 33. Characterization of peripheral autoregulatory mechanisms that prevent development of cyclosporin-induced syngeneic graft-versus-host disease.
    Hess AD; Fischer AC; Horwitz L; Bright EC; Laulis MK
    J Immunol; 1994 Jul; 153(1):400-11. PubMed ID: 8207251
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of thalidomide in the treatment of refractory chronic graft-versus-host disease following bone marrow transplantation in children.
    Rovelli A; Arrigo C; Nesi F; Balduzzi A; Nicolini B; Locasciulli A; Vassallo E; Miniero R; Uderzo C
    Bone Marrow Transplant; 1998 Mar; 21(6):577-81. PubMed ID: 9543061
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Induction of tolerance to cardiac allografts in syngeneic radiation chimeras: importance of repopulating immune cell type.
    Dittmer JE; Bennett M; Moran T
    Transplant Proc; 1981 Mar; 13(1 Pt 1):616-8. PubMed ID: 7022901
    [No Abstract]   [Full Text] [Related]  

  • 36. Immune-related injury to endothelium associated with acute graft-versus-host disease in the rat.
    Beschorner WE; Shinn CA; Hess AD; Suresch DL; Santos GW
    Transplant Proc; 1989 Feb; 21(1 Pt 3):3025-7. PubMed ID: 2468250
    [No Abstract]   [Full Text] [Related]  

  • 37. Vascularized lymph node transplantation induces graft-versus-host disease in chimeric hosts.
    Francois CG; Brouha PC; Laurentin-Perez LA; Perez-Abadia G; Grossi FV; Barker JH; Hewitt CW; Kon M; Ramsamooj R; Maldonado C
    Transplantation; 2006 May; 81(10):1435-41. PubMed ID: 16732182
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of transient treatment with FK506 in the early phase on cyclophosphamide-induced bone marrow chimerism and transplant tolerance across MHC barriers.
    Okayama J; Ko S; Kanehiro H; Kanokogi H; Nakajima Y
    J Surg Res; 2006 Jun; 133(2):61-8. PubMed ID: 16376943
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of thalidomide for CGVHD defended.
    Altomonte V
    Oncol Nurs Forum; 1993 Apr; 20(3):428. PubMed ID: 8497414
    [No Abstract]   [Full Text] [Related]  

  • 40. Failure of thalidomide to control bronchiolitis obliterans post bone marrow transplant.
    Heaton DC
    Bone Marrow Transplant; 1989 Sep; 4(5):598. PubMed ID: 2790340
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.